Search results for "Recurrent"

showing 10 items of 256 documents

Effectiveness of amlexanox and adcortyl for the treatment of recurrent aphthous ulcers

2015

Background Recurrent aphthous stomatitis (RAS) is a common condition that affects approximately 20% of the general population. The ulcers can interfere with speech and eating and cause significant pain and discomfort. This study aimed to evaluate the efficacy of Amlexanox and Adcortyl in the treatment of aphthous ulcers. Material and Methods In this randomized double blind clinical trial with sequential patient entry, a total of 40 patients who presented with aphthous ulcers were included. Patients were received Amlexanox or Adcortyl four times daily for 7 days. Patients were evaluated for pain, lesion size, and tingling at one day, three days, five days and seven days follow-ups. The treat…

medicine.medical_specialtyPopulationOdontologíaRecurrent aphthous stomatitisDouble blindLesion03 medical and health sciences0302 clinical medicinemedicineeducationGeneral DentistryPain scoreeducation.field_of_studyOral Medicine and Pathologybusiness.industryResearch030206 dentistryCiencias de la saludDermatologySurgeryClinical trialAmlexanox030220 oncology & carcinogenesisUNESCO::CIENCIAS MÃ DICASTingling:CIENCIAS MÃ DICAS [UNESCO]medicine.symptombusinessmedicine.drugJournal of Clinical and Experimental Dentistry
researchProduct

Predicting adverse obstetric outcome after early pregnancy events and complications: a review.

2009

BACKGROUND The aim was to evaluate the impact of early pregnancy events and complications as predictors of adverse obstetric outcome. METHODS We conducted a literature review on the impact of first trimester complications in previous and index pregnancies using Medline and Cochrane databases covering the period 1980-2008. RESULTS Clinically relevant associations of adverse outcome in the subsequent pregnancy with an odds ratio (OR) > 2.0 after complications in a previous pregnancy are the risk of perinatal death after a single previous miscarriage, the risk of very preterm delivery (VPTD) after two or more miscarriages, the risk of placenta praevia, premature preterm rupture of membranes, V…

medicine.medical_specialtyPopulationRisk AssessmentCrown-Rump LengthMiscarriageHyperemesis gravidarumPregnancyRecurrent miscarriagemedicineBirth WeightHumanseducationreproductive and urinary physiologyPregnancyeducation.field_of_studyPlacental abruptionObstetricsbusiness.industryPregnancy OutcomeObstetrics and GynecologyAbortion Inducedmedicine.diseasePrognosisPregnancy ComplicationsLow birth weightPregnancy Trimester FirstReproductive MedicineApgar scoreFemalemedicine.symptombusinessHuman reproduction update
researchProduct

Risk of Recurrence After a First Episode of Symptomatic Venous Thromboembolism Provoked by a Transient Risk Factor A Systematic Review

2010

Background We aimed to determine the risk of recurrence for symptomatic venous thromboembolism (VTE) provoked by different transient risk factors. Data Sources MEDLINE, EMBASE, and Cochrane Collaboration Registry of Randomized Trials databases were searched. Study Selection Prospective cohort studies and randomized trials of patients with a first episode of symptomatic VTE provoked by a transient risk factor and treated for at least 3 months were identified. Data Extraction Number of patients and recurrent VTE during the 0- to 12-month and 0- to 24-month intervals after stopping therapy, study design, and provoking risk factor characteristics were extracted. Data Synthesis Annualized recurr…

medicine.medical_specialtyRate ratioRisk Assessmentlaw.inventionRandomized controlled triallawRecurrenceRisk FactorsInternal medicineEpidemiologyInternal MedicinemedicineHumansRisk factorProspective cohort studyFirst episodebusiness.industryIncidence (epidemiology)IncidenceVenous Thromboembolismvenous thrombosis recurrent eventmedicine.diseasePrognosisSurgeryVenous thrombosisbusiness
researchProduct

Repeated resection for recurrent intrahepatic cholangiocarcinoma: A retrospective German multicentre study.

2020

Background Tumour recurrence is common after resection of intrahepatic cholangiocarcinoma (ICC). Repeated resection is a potential curative treatment, but outcomes are not well-defined thus far. The aim of this retrospective multicentre cohort study was to show the feasibility and survival of repeated resection of ICC recurrence. Methods Data were collected from 18 German hepato-pancreatico-biliary centres for patients who underwent repeated exploration of recurrent ICC between January 2008 and December 2017. Primary end points were overall (OS) and recurrence-free survival from the day of primary and repeated resection. Results Of 156 patients who underwent repeated exploration for recurre…

medicine.medical_specialtyResectionCholangiocarcinomaCohort Studies03 medical and health sciences0302 clinical medicineMedicineHepatectomyHumansIntrahepatic CholangiocarcinomaRetrospective StudiesHepatologybusiness.industryPrimary resectionRecurrent Intrahepatic Cholangiocarcinoma3. Good healthTumor recurrenceSurgeryTreatment OutcomeBile Duct NeoplasmsMedian timeCurative treatment030220 oncology & carcinogenesis030211 gastroenterology & hepatologyNeoplasm Recurrence LocalbusinessCohort studyLiver international : official journal of the International Association for the Study of the LiverReferences
researchProduct

Narratives of Patients with Fatal Outcomes During the Phase 2 TITAN and Phase 3 HERCULES Studies

2019

Background: Acquired thrombotic thrombocytopenic purpura (aTTP) is a rare but life-threatening thrombotic microangiopathy, with an untreated mortality rate of >90%. Prompt treatment with therapeutic plasma exchange (TPE) and immunosuppression improves outcomes in patients with aTTP, but 10-20% of patients still die acutely from this disease. The aim of this analysis was to describe in more detail the characteristics and disease courses of the patients who died during the caplacizumab clinical development program. Methods: Patient narratives on all deaths occurring during the phase 2 TITAN and phase 3 HERCULES studies were extracted. Results: In the overall study periods, a total of 6 pat…

medicine.medical_specialtyStudy drugbusiness.operationbusiness.industryRecurrent episodeImmunologyCell BiologyHematologyOctapharmaPlaceboBiochemistryAdamts13 activityFamily medicinemedicineRisk of mortalityDisease characteristicsIn patientbusinessBlood
researchProduct

Surgical Approach to Recurrent Cholangiocarcinoma.

2020

<b><i>Background:</i></b> For recurrent cholangiocarcinoma, systemic chemotherapy is the standard of care. Repeated resection is a potential curative treatment, but data are scarce and outcomes are not well defined so far. <b><i>Summary:</i></b> In the last decade there has been an increasing number of reports suggesting a survival benefit and even cure after repeated surgery. This is particularly true for intrahepatic cholangiocarcinoma, where repeated resections offer similar or even better results than the first resection. In selected cases even a third liver resection is possible. In contrast, in perihilar and distal cholangiocarcinoma, re…

medicine.medical_specialtySurgical approachStandard of carebusiness.industryTumor biologySystemic chemotherapyGeneral surgeryGastroenterologyReview Article030230 surgeryResection03 medical and health sciences0302 clinical medicineMedicine030211 gastroenterology & hepatologySurgeryRecurrent CholangiocarcinomabusinessSurgical treatmentIntrahepatic CholangiocarcinomaVisceral medicine
researchProduct

How should we determine length of anticoagulation after proximal deep vein thrombosis of the lower limbs?

2009

The current approach for deciding the duration of vitamin K antagonist (VKA) treatment after an episode of venous thrombo-embolism (VTE) is mainly based on the characteristic of the index event (3 months or longer in case of unknown/persistent risk factors, 3 months or less in case of removable causes). However, the length of anticoagulation should be tailored on the patient's risk for recurrent thrombosis as well as for bleeding, but such 'time for decision' is often unclear and the optimal duration of VKA remains debatable. The presence of persistent residual vein thrombosis and increased D-dimer levels after stopping therapy are predictors for recurrent deep vein thrombosis (DVT). Manage…

medicine.medical_specialtyTime FactorsVitamin Kmedicine.drug_classDeep veinRisk AssessmentDrug Administration ScheduleRecurrent deep vein thrombosisSettore MED/15 - Malattie Del SangueFibrin Fibrinogen Degradation ProductsFibrinolytic AgentsRecurrenceNeoplasmsmedicineHumansVenous ThrombosisFirst episodebusiness.industryVascular diseaseAnticoagulantVitaminsHematologyVitamin K antagonistmedicine.diseaseThrombosisduration anticoagulants venous thromboembolismSurgeryVenous thrombosismedicine.anatomical_structurebusinessBiomarkersBritish Journal of Haematology
researchProduct

ASO Authors Reflections: Vaginectomy as Surgical Treatment of Recurrent Cervical Cancer

2020

medicine.medical_specialtyVaginal Neoplasmsmedicine.medical_treatmentMEDLINERecurrent cervical cancerUterine Cervical NeoplasmsColpotomyHysterectomyVaginectomyColpotomy; Female; Humans; Hysterectomy; Neoplasm Recurrence Local; Pregnancy; Uterine Cervical Neoplasms; Vaginal NeoplasmsNeoplasm RecurrenceSurgical oncologyPregnancymedicineHumansSurgical treatmentPregnancyHysterectomybusiness.industryGeneral surgeryVaginectomymedicine.diseaseOncologySurgeryFemaleNeoplasm Recurrence Localbusiness
researchProduct

Photobiomodulation therapy for the management of recurrent aphthous stomatitis in children : clinical effectiveness and parental satisfaction

2020

Background This study aims to evaluate the effectiveness of the photobiomodulation therapy (PBMT) in the treatment of minor recurrent aphthous stomatitis (MiRAS) in children, in terms of pain relief, lesion size reduction and the parental satisfaction of the therapy. Material and Methods This randomized controlled study was carried out on 60 children with clinical diagnosis of MiRAS. Patients were randomized into two groups: group A receiving laser therapy and group B receiving sham therapy (placebo). Laser therapy (diode laser, λ: 645 nm) was administered on day 1 (T0) for three consecutive days. Patients were evaluated also on day 4 (T1), on day 7 (T2) and on day 10 (T3). Oral aphthous le…

medicine.medical_specialtyVisual analogue scaleChildren; Lasers; UlcersPersonal SatisfactionPlaceboRecurrent aphthous stomatitisPeriodontal probeGroup Blaw.inventionLesion03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicinemedicineHumansLow-Level Light TherapyChildChildrenGeneral DentistryStomatitisPain MeasurementUlcersOral Medicine and Pathologybusiness.industryResearchLasers030206 dentistrymedicine.disease:CIENCIAS MÉDICAS [UNESCO]Treatment OutcomeOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASStomatitis AphthousSurgerymedicine.symptombusiness
researchProduct

Eradication of Helicobacter pylori in Recurrent Duodenal Ulcer

1993

medicine.medical_specialtybiologybusiness.industryInternal medicinemedicineGeneral MedicineHelicobacter pyloriRecurrent duodenal ulcerbiology.organism_classificationbusinessGastroenterologyNew England Journal of Medicine
researchProduct